Clinical Trial Update: Novel Serum Biomarkers for Identifying Plaque Erosion in ACS and Predicting Prognosis

View source ↗

Summary

This clinical trial update describes novel serum biomarkers intended to identify plaque erosion in acute coronary syndromes and to predict patient prognosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Xuebo Liu | Conditions: Plaque Rupture, Acute Coronary Syndromes | Status: ACTIVE_NOT_RECRUITING